How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers.
Saved in:
| Title: | How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers. |
|---|---|
| Authors: | Li R; Rebecca Li, Ph.D., is at the Vivli Center for Global Clinical Research Data and the Center for Bioethics at Harvard Medical School. Ida Sim, M.D., Ph.D., is at the Vivli Center for Global Clinical Research Data and at the University of California, San Francisco., Sim I; Rebecca Li, Ph.D., is at the Vivli Center for Global Clinical Research Data and the Center for Bioethics at Harvard Medical School. Ida Sim, M.D., Ph.D., is at the Vivli Center for Global Clinical Research Data and at the University of California, San Francisco. |
| Source: | The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2019 Sep; Vol. 47 (3), pp. 369-373. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium: Internet ISSN: 1748-720X (Electronic) Linking ISSN: 10731105 NLM ISO Abbreviation: J Law Med Ethics |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1748-720X |
|---|---|
| DOI: | 10.1177/1073110519876165 |
